Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KEPPRA 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/KEPPRA 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

KEPPRA 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Ucb Pharma🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 4, 2024
Approval ID: 8625f3902d59c16c
Company: Ucb Pharma
Type: Standard

Approval Details

Approval Id: 8625f3902d59c16c
Drug Cima Aemps Name: KEPPRA 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 00146022IP5
Holder Company Name: Ucb Pharma
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/ucb-pharma-sa
Authorization Date: 2024-01-04
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 1000 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Ucb Pharma
Company Detail Path: /organization/ucb-pharma-sa

Company Information

Pharmaceutical Company Name: UCB S.A.
Name En: UCB S.A.
Country Name: Belgium
City Name: Brussels
Address: Brussels, Belgium
Website: https://www.ucb.com

Active Ingredients

LEVETIRACETAM

1000 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 4, 2024

Approval ID

8625f3902d59c16c

Type

Standard

Back to CIMA-AEMPS Approvals